Defibrillator

DEVICE3 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI), Abbott Medical Devices, Minneapolis Heart Institute Foundation

Conditions

ArrhythmiaCoronary Artery DiseaseDeath, Sudden, CardiacDefibrillatorHeart ArrestHeart DiseasesLeft Ventricular DysfunctionMyocardial Infarction

Phase 3

Public Access Defibrillation (PAD) Community Trial

CompletedNCT00004560

National Heart, Lung, and Blood Institute (NHLBI)Arrhythmia, Death, Sudden, Cardiac, Heart Arrest +3

Start: 1999-09-30End: 2004-02-29Updated: 2016-04-14

Unknown Phase

DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation

TerminatedNCT00487279

Abbott Medical DevicesCoronary Artery Disease, Left Ventricular Dysfunction, Sudden Cardiac Death

Start: 2007-06-30End: 2011-04-30Updated: 2019-02-05

Early Feasibility Study of 3930M Defibrillation Lead Implantation Via the Middle Cardiac Vein in Patients With Tricuspid Valve Regurgitation

Not yet recruitingNCT07811609

Minneapolis Heart Institute FoundationDefibrillator, Tricuspid Valve Regurgitation

Start: 2026-11-01End: 2028-01-01Target: 5Updated: 2026-09-10